Dr. Anthony Guiseppi-Elie has been named associate dean of Engineering Medicine (EnMed) at Texas A&M University. He is currently a TEES Research Professor and professor in the Department of Biomedical Engineering with a courtesy appointment in the Department of Electrical and Computer Engineering.
EnMed is Texas A&M University’s innovative engineering medicine school option at Houston Methodist Hospital, developed to educate a new kind of physician to create transformational technology for health care.
“I welcome the opportunity to represent the college of engineering on the leadership of EnMed and to work closely with my colleagues in the college of medicine and at Houston Methodist Hospital to realize one of Texas A&M’s most ambitious undertakings as we continue to lead the world with innovative academic programs intended to impact patient outcomes,” said Guiseppi-Elie.
Guiseppi-Elie isworld-renowned researcher whose interests are in engineered bioanalytical microsystems in the service of human health and medicine. This includes bionanotechnology, microfabrication and 3D printing of bio- and electroresponsive hydrogels, BioMEMS, physiology-on-a-chip, ABIO-BIO interfaces, and interfacing of biology and engineering at the molecular, cellular and tissue length scales.
He has published more than 150 archival scientific papers, 31 books or proceedings chapters, holds eight U.S. and foreign patents and has given over 200 invited lectures. He is an editor-in-chief of Bioengineering, an associate editor of Biomedical Microdevices and a member of the editorial boards of The Journal of Bioactive and Compatible Polymers, NanoBiotechnology, and Applied Biochemistry and Biotechnology. He has been a guest editor for the Institute of Electrical and Electronics Engineers (IEEE) Journal of Biomedical and Health Informatics.
Guiseppi-Elie is a Fulbright Specialist Award recipient in bioengineering at the University of Tucumán in Tucumán, Argentina, and has been an IEEE-Engineering in Medicine and Biology Society Distinguished Lecturer. He is a fellow of the American Institute of Medical and Biological Engineering, the Royal Society of Chemistry and IEEE, a lifetime member of the American Institute of Chemical Engineers and holds memberships in many other prominent organizations.
Guiseppi-Elie will assume his new role on Dec. 3.
EnMed is Texas A&M University’s innovative engineering medicine school option at Houston Methodist Hospital, developed to educate a new kind of physician to create transformational technology for health care.
“I welcome the opportunity to represent the college of engineering on the leadership of EnMed and to work closely with my colleagues in the college of medicine and at Houston Methodist Hospital to realize one of Texas A&M’s most ambitious undertakings as we continue to lead the world with innovative academic programs intended to impact patient outcomes,” said Guiseppi-Elie.
Guiseppi-Elie is
He has published more than 150 archival scientific papers, 31 books or proceedings chapters, holds eight U.S. and foreign patents and has given over 200 invited lectures. He is an editor-in-chief of Bioengineering, an associate editor of Biomedical Microdevices and a member of the editorial boards of The Journal of Bioactive and Compatible Polymers, NanoBiotechnology, and Applied Biochemistry and Biotechnology. He has been a guest editor for the Institute of Electrical and Electronics Engineers (IEEE) Journal of Biomedical and Health Informatics.
Guiseppi-Elie is a Fulbright Specialist Award recipient in bioengineering at the University of Tucumán in Tucumán, Argentina, and has been an IEEE-Engineering in Medicine and Biology Society Distinguished Lecturer. He is a fellow of the American Institute of Medical and Biological Engineering, the Royal Society of Chemistry and IEEE, a lifetime member of the American Institute of Chemical Engineers and holds memberships in many other prominent organizations.
Guiseppi-Elie will assume his new role on Dec. 3.